Patrick Zammit - 04 Oct 2022 Form 4 Insider Report for TD SYNNEX CORP (SNX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Oct 2022, 15:13:13 UTC
Prior SEC filing
02 Sep 2022
Next SEC filing
16 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cheryl Grant, attorney-in-fact
Filing notes and source

Key filing fact

Patrick Zammit filed Form 4 for TD SYNNEX CORP (SNX) on 06 Oct 2022.

Key facts

  • This page summarizes Patrick Zammit's Form 4 filing for TD SYNNEX CORP (SNX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Oct 2022, 15:13.

Change

  • Previous filing in this sequence was filed on 02 Sep 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNX transaction

Common Stock

Award

Transaction value
$0
Shares
+4,611
Change %
+4.3%
Price
$0.000000
Shares after
111,463
Date
04 Oct 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock issuable upon settlement of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest as to 1/3 of the shares on each of the first three anniversaries of October 4, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .